mannitol has been researched along with albuterol in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.70) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 25 (67.57) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jain, NK; Khopade, AJ; Sant, VP | 1 |
| Marriott, C; Martin, GP; Tee, SK; Zeng, XM | 1 |
| Forbes, B; Lansley, AB; Martin, GP; Shah, A | 1 |
| Harjunen, P; Järvinen, K; Lankinen, T; Lehto, VP; Salonen, H | 1 |
| Mashru, RC; Parikh, PP; Sankalia, MG; Sutariya, VB | 1 |
| Benetis, R; Gendviliene, V; Gurskaite, H; Jurevicius, J; Kanaporis, G; Macianskiene, R; Skeberdis, VA; Zablockaite, D | 1 |
| Adi, H; Larson, I; Stewart, PJ | 1 |
| Butt, HJ; Kappl, M; Lippold, BC; Lohrmann, M; Urbanetz, NA | 1 |
| Boshhiha, AM; Urbanetz, NA | 1 |
| Adi, H; Chan, HK; Heng, D; Kumon, M; Kwok, PC | 1 |
| Kaialy, W; Martin, GP; Momin, MN; Nokhodchi, A; Ticehurst, MD | 1 |
| Kaialy, W; Momin, MN; Murphy, J; Nokhodchi, A; Ticehurst, MD | 1 |
| Clearie, KL; Lipworth, BJ; McKinlay, L; Williamson, PA | 1 |
| Alhalaweh, A; Kaialy, W; Nokhodchi, A; Velaga, SP | 1 |
| Kaialy, W; Larhrib, H; Martin, GP; Nokhodchi, A | 1 |
| Achelis, L; Littringer, EM; Mescher, A; Schroettner, H; Urbanetz, NA; Walzel, P | 1 |
| Hindle, M; Longest, PW | 1 |
| Kaialy, W; Nokhodchi, A | 4 |
| Halkola, T; Hirvonen, J; Järvinen, K; Kauppinen, EI; Laaksonen, T; Peltonen, L; Pessi, J; Rahikkala, A; Raula, J | 1 |
| Hindle, M; Li, X; Longest, PW; Tian, G | 1 |
| Hindle, M; Longest, PW; Son, YJ; Tian, G | 1 |
| Alhalaweh, A; Hussain, T; Kaialy, W; Nokhodchi, A | 1 |
| Ballerin, G; Buddle, L; Morgan, L; Ong, HX; Scalia, S; Traini, D; Young, PM | 1 |
| Faulhammer, E; Khinast, JG; Paudel, A; Wahl, V; Zellnitz, S | 1 |
| Buckton, G; Jones, MD | 1 |
| Fakner, P; Kamplade, J; Mönckedieck, M; Scherließ, R; Steckel, H; Urbanetz, NA; Walzel, P | 1 |
| Brunsteiner, M; Khinast, J; Paudel, A; Pinto, JT; Schroettner, H; Zellnitz, S | 1 |
| Birk, G; Hertel, N; Scherließ, R | 1 |
| Ferdynand, MS; Nokhodchi, A | 1 |
1 review(s) available for mannitol and albuterol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for mannitol and albuterol
| Article | Year |
|---|---|
Fluticasone/Salmeterol combination confers benefits in people with asthma who smoke.
Topics: Adult; Albuterol; Androstadienes; Asthma; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Glucocorticoids; Humans; Male; Mannitol; Methacholine Chloride; Placebos; Smoking; Spirometry; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2012 |
35 other study(ies) available for mannitol and albuterol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Iontophoretic transdermal delivery of salbutamol: methyl-orange ion-pair.
Topics: Administration, Cutaneous; Adrenergic alpha-Antagonists; Albuterol; Animals; Azo Compounds; Hydrogen-Ion Concentration; In Vitro Techniques; Indicators and Reagents; Ion Exchange; Iontophoresis; Mannitol; Permeability; Rabbits; Skin Absorption | 1998 |
The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Carbohydrates; Chemistry, Pharmaceutical; Drug Carriers; Lactose; Mannitol; Particle Size; Pharmaceutic Aids; Powders; Sorbitol | 2000 |
The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport.
Topics: Albuterol; Biological Transport; Bronchi; Cell Line; Electric Impedance; Epithelial Cells; Humans; Mannitol; Permeability | 2003 |
Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI.
Topics: Albuterol; Budesonide; Chemistry, Pharmaceutical; Drug Carriers; Drug Storage; Glucose; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Lung; Mannitol; Nebulizers and Vaporizers; Powders | 2003 |
Development and evaluation of fast-dissolving film of salbutamol sulphate.
Topics: Albuterol; Algorithms; Anti-Asthmatic Agents; Area Under Curve; Bronchodilator Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Excipients; Glycerol; Mannitol; Membranes, Artificial; Microscopy, Electron, Scanning; Models, Statistical; Polyvinyl Alcohol; Solubility; Tensile Strength | 2005 |
Effect of hyperosmolarity on beta2-adrenergic stimulation in human atrium.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Calcium Channels, L-Type; Diuretics, Osmotic; Dose-Response Relationship, Drug; Heart Atria; Humans; Mannitol; Middle Aged; Myocardial Contraction; Myocytes, Cardiac; Osmolar Concentration; Osmotic Pressure; Time Factors | 2005 |
Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
Topics: Administration, Inhalation; Albuterol; Carbohydrates; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Desiccation; Drug Carriers; Drug Compounding; Excipients; Glucose; Lactose; Lasers; Mannitol; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Reproducibility of Results; Salmeterol Xinafoate; Sorbitol; Surface Properties; Technology, Pharmaceutical; Water | 2007 |
Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
Topics: Adhesiveness; Administration, Inhalation; Albuterol; Bronchodilator Agents; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Interactions; Lasers; Mannitol; Microscopy, Atomic Force; Nebulizers and Vaporizers; Particle Size; Powders; Sulfates; Technology, Pharmaceutical; Tensile Strength | 2007 |
Influence of carrier surface fines on dry powder inhalation formulations.
Topics: Administration, Inhalation; Albuterol; Drug Carriers; Lactose; Mannitol; Particle Size; Powders; Surface Properties | 2009 |
Can low-dose combination products for inhalation be formulated in single crystalline particles?
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Budesonide; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Drug Combinations; Ethanolamines; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Mannitol; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Photoelectron Spectroscopy; Surface Properties; Transition Temperature; X-Ray Diffraction | 2010 |
The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Crystallization; Drug Carriers; Excipients; Mannitol; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Powders; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2010 |
Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
Topics: Albuterol; Calorimetry, Differential Scanning; Crystallization; Drug Carriers; Drug Delivery Systems; Lung; Mannitol; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Powders; Spectroscopy, Fourier Transform Infrared; Surface Properties; X-Ray Diffraction | 2010 |
Effect of carrier particle shape on dry powder inhaler performance.
Topics: Albuterol; Bronchodilator Agents; Drug Carriers; Dry Powder Inhalers; Lactose; Mannitol; Particle Size; Porosity; Rheology | 2011 |
The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Calorimetry, Differential Scanning; Crystallization; Drug Carriers; Dry Powder Inhalers; Humans; Lactose; Mannitol; Particle Size; Powder Diffraction; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2012 |
Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
Topics: Administration, Inhalation; Albuterol; Drug Carriers; Drug Delivery Systems; Dry Powder Inhalers; Lung; Mannitol; Particle Size; Pilot Projects; Surface Properties; Temperature | 2012 |
Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Chemistry, Pharmaceutical; Citric Acid; Drug Combinations; Drug Delivery Systems; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Lung; Mannitol; Metered Dose Inhalers; Models, Anatomic; Nanoparticles; Particle Size; Respiratory Mucosa; Sodium Chloride | 2012 |
Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Drug Carriers; Drug Delivery Systems; Dry Powder Inhalers; Freeze Drying; Lung; Mannitol; Particle Size; Powders | 2013 |
Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Compounding; Drug Delivery Systems; Excipients; Feasibility Studies; Glucocorticoids; Leucine; Mannitol; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Solubility; Time Factors | 2013 |
Targeting aerosol deposition to and within the lung airways using excipient enhanced growth.
Topics: Administration, Inhalation; Aerosols; Albuterol; Drug Delivery Systems; Excipients; Hydrodynamics; Hygroscopic Agents; Insulin; Lung; Mannitol; Models, Theoretical; Nebulizers and Vaporizers; Particle Size; Respiratory System; Sodium Chloride; Solubility; Thermodynamics; Tissue Distribution | 2013 |
Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
Topics: Administration, Inhalation; Aerosols; Albuterol; Calorimetry, Differential Scanning; Crystallization; Drug Delivery Systems; Lung; Mannitol; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Powders; Spectroscopy, Fourier Transform Infrared | 2013 |
Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.
Topics: Albuterol; Chemical Engineering; Chemistry, Pharmaceutical; Dry Powder Inhalers; Lactose; Mannitol; Particle Size; Sulfates; X-Ray Diffraction | 2013 |
Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.
Topics: Aerosols; Albuterol; Bronchodilator Agents; Dry Powder Inhalers; Excipients; Leucine; Mannitol; Particle Size | 2013 |
Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.
Topics: Administration, Inhalation; Albuterol; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Mannitol; Microspheres; Particle Size; Porosity; Powders | 2014 |
Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Cells, Cultured; Cilia; Drug Therapy, Combination; Humans; Lung Diseases; Mannitol; Microscopy, Electron, Scanning; Mucus; Muscle, Smooth | 2014 |
Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
Topics: Aerosols; Albuterol; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Freeze Drying; Mannitol; Particle Size; Powders | 2015 |
Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Capsules; Desiccation; Drug Carriers; Drug Compounding; Dry Powder Inhalers; Lactose; Mannitol; Particle Size; Porosity; Powders | 2015 |
Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Topics: Adhesiveness; Administration, Inhalation; Albuterol; Beclomethasone; Budesonide; Chemistry, Pharmaceutical; Chromatography, Gas; Colloids; Drug Carriers; Dry Powder Inhalers; Erythritol; Lactose; Mannitol; Microscopy, Atomic Force; Particle Size; Pharmaceutical Preparations; Powders; Solubility; Terbutaline; Triamcinolone Acetonide | 2016 |
Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
Topics: Administration, Inhalation; Aerosols; Albuterol; Drug Carriers; Dry Powder Inhalers; Lactose; Mannitol; Particle Size; Powders | 2017 |
Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate.
Topics: Administration, Inhalation; Albuterol; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Excipients; Humans; Mannitol; Particle Size; Powders; Surface Properties | 2019 |
Particle engineered mannitol for carrier-based inhalation - A serious alternative?
Topics: Administration, Inhalation; Albuterol; Budesonide; Drug Carriers; Dry Powder Inhalers; Lactose; Mannitol; Mechanical Phenomena; Particle Size | 2020 |
Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
Topics: Albuterol; Dry Powder Inhalers; Lactose; Mannitol; Particle Size; Sulfates; Technology, Pharmaceutical | 2020 |